Cargando…
The surgical outcomes and risk factors of giant hepatic haemangiomas: a single centre experience
OBJECTIVE: To evaluate the safety of performing surgery on cavernous haemangiomas in the liver larger than 10 cm and establish preoperative predictors of intraoperative blood transfusion and morbidity. METHODS: A total of 373 patients with haemangiomas larger than 10 cm who underwent surgery in our...
Autores principales: | Dong, Zhitao, Fang, Kunpeng, Sui, Chengjun, Guo, Junwu, Dai, Binghua, Geng, Li, Yang, Jiamei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290193/ https://www.ncbi.nlm.nih.gov/pubmed/35843944 http://dx.doi.org/10.1186/s12893-022-01721-w |
Ejemplares similares
-
LncRNA FOXD2‐AS1 as a competitive endogenous RNA against miR‐150‐5p reverses resistance to sorafenib in hepatocellular carcinoma
por: Sui, Chengjun, et al.
Publicado: (2019) -
Enucleation for Giant Liver Haemangioma
por: Nagorney, David M.
Publicado: (1994) -
Congenital haemangiomas: a single-centre retrospective review
por: Braun, Victoire, et al.
Publicado: (2020) -
Treatment of Infantile Haemangioma – Perspective of a Regional Surgical Centre
por: Ho, Weiguang, et al.
Publicado: (2019) -
circFN1 Mediates Sorafenib Resistance of Hepatocellular Carcinoma Cells by Sponging miR-1205 and Regulating E2F1 Expression
por: Yang, Cheng, et al.
Publicado: (2020)